Peripheral artery disease in patients with schizophrenia as compared to controls

Patients with schizophrenia have an increased prevalence of risk factors for peripheral artery disease (PAD) and is expected to have an increased prevalence of PAD. PAD can be detected utilizing toe-brachial index (TBI) which screens for vascular pathology proximal to the toes. Using a cross-section...

Full description

Saved in:
Bibliographic Details
Published in:BMC cardiovascular disorders 2023-03, Vol.23 (1), p.126-126, Article 126
Main Authors: Jørgensen, Linea Rosenberg, Hegtmann, Cathrine Linnea, Straszek, Sune P V, Høyer, Christian, Polcwiartek, Christoffer, Petersen, Lars J, Dalgaard, Martin Kamp, Jensen, Svend Eggert, Nielsen, René Ernst
Format: Article
Language:English
Subjects:
Age
Analysis
Ankle Brachial Index
Atherosclerosis
Blood pressure
Blood Pressure - physiology
Body mass index
Cardiovascular disease
Care and treatment
Cohort analysis
Comorbidity
Complications and side effects
Consent
Cross-Sectional Studies
Diabetes mellitus
Diagnosis
Disease prevention
Fingers & toes
Hallucinations
Heart diseases
Hemodynamics
Humans
Life expectancy
Medicine, Preventive
Mental disorders
Methods
Mortality
Patients
Peripheral Arterial Disease - diagnosis
Peripheral Arterial Disease - epidemiology
Peripheral artery disease
Peripheral vascular diseases
Prevalence
Prevention
Preventive health services
Risk Factors
Schizophrenia
Schizophrenia - diagnosis
Schizophrenia - epidemiology
Skin
Smoking
Statistical analysis
Toe–brachial index
Values
Vascular diseases
Vein & artery diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Patients with schizophrenia have an increased prevalence of risk factors for peripheral artery disease (PAD) and is expected to have an increased prevalence of PAD. PAD can be detected utilizing toe-brachial index (TBI) which screens for vascular pathology proximal to the toes. Using a cross-sectional design, we defined the subpopulations: (1) Patients diagnosed with schizophrenia less than 2 years before inclusion (SCZ 
ISSN:1471-2261
1471-2261
DOI:10.1186/s12872-023-03143-9